Skip to main content
. 2012 Dec 21;207(6):893–897. doi: 10.1093/infdis/jis925

Figure 2.

Figure 2.

Association between baseline minority nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance mutation and the resistance detected by standard genotyping after virologic failure (VF) for those on an efavirenz-based regimen (A) or nevirapine-based regimen (B).